United Asset Strategies, Inc. Eli Lilly & CO Transaction History

United Asset Strategies, Inc.

$1.07 Billion
Q3 2024

A detailed history of United Asset Strategies, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, United Asset Strategies, Inc. holds 4,143 shares of LLY stock, worth $3.01 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

4,143

Previous 5,296 21.77%

Holding current value

$3.01 Million

Previous $4.79 Million 23.45%

% of portfolio

0.34%

Previous 0.48%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$772.14 - $960.02 $890,277 - $1.11 Million	-1,153 Reduced 21.77%	4,143 $3.67 Million
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $155,122 - $194,534	214 Added 4.21%	5,296 $4.79 Million
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $103,042 - $137,856	174 Added 3.55%	5,082 $3.95 Million
Q4 2023 Jan 30, 2024	SELL	$525.19 - $619.13 $108,189 - $127,540	-206 Reduced 4.03%	4,908 $2.86 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $217,350 - $299,650	-500 Reduced 8.91%	5,114 $2.75 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $614,145 - $821,183	1,751 Added 45.33%	5,614 $2.63 Million
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $46,283 - $54,358	-149 Reduced 3.71%	3,863 $1.33 Million
Q4 2022 Jan 26, 2023	BUY	$321.55 - $374.67 $1.07 Million - $1.25 Million	3,333 Added 490.87%	4,012 $0
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $889 - $1,013	-3 Reduced 0.44%	679 $220,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $190,093 - $223,198	682 New	682 $221,000
Q1 2022 Apr 29, 2022	SELL	$234.69 - $291.66 $176,017 - $218,745	-750 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $168,637 - $209,280	750 New	750 $207,000
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $485,050 - $641,838	-3,718 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$146.22 - $169.13 $53,224 - $61,563	364 Added 10.85%	3,718 $550,000
Q2 2020 Aug 03, 2020	BUY	$136.42 - $164.18 $457,552 - $550,659	3,354 New	3,354 $551,000
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $458,151 - $539,278	-4,116 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $962,101 - $1.08 Million	-9,085 Reduced 68.82%	4,116 $476,000
Q3 2018 Nov 07, 2018	BUY	$85.86 - $107.31 $68,086 - $85,096	793 Added 6.39%	13,201 $1.42 Million
Q2 2018 Aug 07, 2018	BUY	$75.7 - $86.88 $131,490 - $150,910	1,737 Added 16.28%	12,408 $1.06 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $56,919 - $67,189	767 Added 7.74%	10,671 $826,000
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $141,838 - $152,137	1,731 Added 21.18%	9,904 $836,000
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $629,893 - $699,118	8,173	8,173 $699,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $691B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Asset Strategies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Asset Strategies, Inc. with notifications on news.

Account

United Asset Strategies, Inc. Eli Lilly & CO Transaction History